Morgan Frank - Net Worth and Insider Trading
Morgan Frank Net Worth
The estimated net worth of Morgan Frank is at least $11 Million dollars as of 2024-09-20. Morgan Frank is the Director or Senior Officer of 10% Security Holder of Eupraxia Pharmaceuticals Inc and owns about 2,784,049 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) stock worth over $11 Million. Details can be seen in Morgan Frank's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Morgan Frank has not made any transactions after 2022-05-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Morgan Frank
Morgan Frank Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Morgan Frank owns 1 companies in total, including Eupraxia Pharmaceuticals Inc (TSX:EPRX) .
Click here to see the complete history of Morgan Frank’s form 4 insider trades.
Insider Ownership Summary of Morgan Frank
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:EPRX | Eupraxia Pharmaceuticals Inc | 2022-05-10 | Director or Senior Officer of 10% Security Holder |
Morgan Frank Latest Holdings Summary
Morgan Frank currently owns a total of 1 stock. Morgan Frank owns 2,784,049 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) as of May 10, 2022, with a value of $11 Million.
Latest Holdings of Morgan Frank
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:EPRX | Eupraxia Pharmaceuticals Inc | 2022-05-10 | 2,784,049 | 3.90 | 10,857,791 |
Holding Weightings of Morgan Frank
Morgan Frank Form 4 Trading Tracker
According to the SEC Form 4 filings, Morgan Frank has made a total of 1 transactions in Eupraxia Pharmaceuticals Inc (TSX:EPRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Eupraxia Pharmaceuticals Inc is the acquisition of 150,000 shares on May 10, 2022, which cost Morgan Frank around $159,000.
Insider Trading History of Morgan Frank
- 1
Morgan Frank Trading Performance
GuruFocus tracks the stock performance after each of Morgan Frank's buying transactions within different timeframes. To be detailed, the average return of stocks after 1 year bought by Morgan Frank is 613%. GuruFocus also compares Morgan Frank's trading performance to market benchmark return within the same time period. The performance of stocks bought by Morgan Frank within 1 year outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Morgan Frank's insider trading performs compared to the benchmark.
Performance of Morgan Frank
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12 | | | | | |
| Relative Return to S&P 500(%) | 14.5 | | | | | |
Morgan Frank Ownership Network
Morgan Frank Owned Company Details
What does Eupraxia Pharmaceuticals Inc do?
Who are the key executives at Eupraxia Pharmaceuticals Inc?
Morgan Frank is the Director or Senior Officer of 10% Security Holder of Eupraxia Pharmaceuticals Inc. Other key executives at Eupraxia Pharmaceuticals Inc include Senior Officer Amanda Michelle Malone , Senior Officer Paul Anthony Brennan , and Director or Senior Officer of 10% Security Holder James Besser .
Eupraxia Pharmaceuticals Inc (TSX:EPRX) Insider Trades Summary
Over the past 18 months, Morgan Frank made no insider transaction in Eupraxia Pharmaceuticals Inc (TSX:EPRX). Other recent insider transactions involving Eupraxia Pharmaceuticals Inc (TSX:EPRX) include a net purchase of 5,000 shares made by Amanda Michelle Malone , a net purchase of 3,800 shares made by Michael Wilmink , and a net purchase of 6,100 shares made by James Allen Helliwell .
In summary, during the past 3 months, insiders sold 0 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) in total and bought 1,900 shares, with a net purchase of 1,900 shares. During the past 18 months, 0 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) were sold and 24,900 shares were bought by its insiders, resulting in a net purchase of 24,900 shares.
Eupraxia Pharmaceuticals Inc (TSX:EPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eupraxia Pharmaceuticals Inc Insider Transactions
Morgan Frank Mailing Address
Above is the net worth, insider trading, and ownership report for Morgan Frank. Currently GuruFocus does not have mailing address information for Morgan Frank.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
